Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Poromov, A. A."'
Autor:
Flora R. Kutueva, Ruslan I. Glushakov, Natalia I. Tapilskaya, Alla E. Nikolaeva, Artem A. Poromov, Olga A. Pustotina
Publikováno v:
Гинекология, Vol 25, Iss 1, Pp 55-61 (2023)
Design. A prospective, multicenter, open-label, randomized, comparative clinical study. Objective. To compare the efficacy and safety of Flucovag (sertaconazole) vaginal suppositories, 300 mg (OTCPharm JSC, Russia; manufactured by Altpharm LLC, Ru
Externí odkaz:
https://doaj.org/article/f9574af59b5d441c81649a78164370ed
Autor:
N. P. Kartashova, A. V. Ivanina, E. A. Glubokova, I. N. Falynskova, A. A. Poromov, I. A. Leneva
Publikováno v:
Антибиотики и Химиотерапия, Vol 67, Iss 9-10, Pp 35-41 (2022)
Interferons (IFN) have antiviral activity against many viruses, including SARS-CoV-2. A combination of IFN-a2b and the antioxidant taurine is widely used in the Russian Federation, and its antiviral activity has not been studied before. The aim of th
Externí odkaz:
https://doaj.org/article/5e1f33ca858a4d47b1e1a1acaae907b6
Autor:
A. A. Poromov, N. R. Makhmudova, I. N. Falynskova, E. A. Glubokova, N. P. Kartashova, I. T. Fedyakina, O. A. Svitich, I. A. Leneva
Publikováno v:
Медицинская иммунология, Vol 22, Iss 1, Pp 99-110 (2020)
Secondary bacterial infections after influenza virus infection further increase morbidity and mortality due to influenza. Despite of seasonal influenza vaccination, antiviral drugs and antibiotics are widely used in viral/bacterial pneumonia therapy.
Externí odkaz:
https://doaj.org/article/de8b54f6a44a4adf9274be541b89aa58
Autor:
Pavel D. Kolesnichenko, Anna A. Peresypkina, Artem A. Poromov, Elena N. Kareva, Alexey V. Tverskoi, Alexey N. Demidenko
Publikováno v:
Research Results in Pharmacology, Vol 5, Iss 1, Pp 45-52 (2019)
Introduction: Evaluation of anti-inflammatory action of Codelac® Broncho with Thymus Serpyllum (elixir) in comparison with Fenspiride was carried out on the model of acute carrageenan inflammation of the paws in rats. Materials and methods: Edema w
Externí odkaz:
https://doaj.org/article/f6df3b96144b479294ab4a58454d8f20
Autor:
N Yu Pshenichnaya, V A Bulgakova, N I Lvov, A A Poromov, E P Selkova, A I Grekova, I V Shestakova, V V Maleev, I A Leneva
Publikováno v:
Терапевтический архив, Vol 91, Iss 3, Pp 56-63 (2019)
In spite of vaccination was recommended by the World Health Organization, the main strategy of influenza is antiviral drugs treatment, one of which is umifenovir. Aim. The aim of the study is to obtain additional data on safety and therapeutic effica
Externí odkaz:
https://doaj.org/article/14725e9611bc4b06bb751561c8d11350
Autor:
Anastasiia V. Gracheva, Ekaterina R. Korchevaya, Roman V. Samoilikov, Daria I. Smirnova, Irina А. Leneva, Artem A. Poromov, Andrey А. Pankratov, Galina V. Trunova, Varvara А. Khokhlova, Firaya G. Nagieva, Oksana А. Svitich, Vitaly V. Zverev, Evgeny В. Faizuloev
Publikováno v:
Medical academic journal. 2:79-88
BACKGROUND: Unprecedented anti-epidemic measures and the widespread use of vaccines against COVID-19 have reduced the rate of hospitalization and mortality from the disease, but have not stopped the SARS-CoV-2 pandemic spread. The development of live
Autor:
Irina Leneva, Nadezhda Kartashova, Artem Poromov, Anastasiia Gracheva, Ekaterina Korchevaya, Ekaterina Glubokova, Olga Borisova, Anna Shtro, Svetlana Loginova, Veronika Shchukina, Ravil Khamitov, Evgeny Faizuloev
Publikováno v:
Viruses, Vol 13, Iss 8, p 1665 (2021)
An escalating pandemic of the novel SARS-CoV-2 virus is impacting global health, and effective antivirals are needed. Umifenovir (Arbidol) is an indole-derivative molecule, licensed in Russia and China for prophylaxis and treatment of influenza and o
Externí odkaz:
https://doaj.org/article/a6576c79bebb4455bd5cf34ea143ca6b
Autor:
V A Bulgakova, A A Poromov, A I Grekova, N Yu Pshenichnaya, E P Selkova, N I Lvov, I A Leneva, I V Shestakova, V V Maleev
Publikováno v:
Терапевтический архив, Vol 89, Iss 1, Pp 62-71 (2017)
Aim. To identify risk factors (RFs) for the development of bacterial complications and the prolonged course of influenza and other acute respiratory viral infections (ARVIs) among inpatients treated in Russian healthcare facilities in the post-pandem
Externí odkaz:
https://doaj.org/article/905672b94af24d2692a1616faee58e62
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Toxicology in Vitro August 2015 29(5):1006-1011